Literature DB >> 16299426

Functional impact and health utility of anxiety disorders in primary care outpatients.

Murray B Stein1, Peter P Roy-Byrne, Michelle G Craske, Alexander Bystritsky, Greer Sullivan, Jeffrey M Pyne, Wayne Katon, Cathy D Sherbourne.   

Abstract

OBJECTIVE: The objective of this study was to examine the relative impact of anxiety disorders and major depression on functional status and health-related quality of life of primary care outpatients.
METHOD: Four hundred eighty adult outpatients at an index visit to their primary care provider were classified by structured diagnostic interview as having anxiety disorders (panic disorder with or without agoraphobia, social phobia, and posttraumatic stress disorder; generalized anxiety disorder was also assessed in a subset) with or without major depression. Functional status, sick days from work, and health-related quality of life (including a preference-based measure) were assessed using standardized measures adjusting for the impact of comorbid medical illnesses. Relative impact of the various anxiety disorders and major depression on these indices was evaluated.
RESULTS: In multivariate regression analyses simultaneously adjusting for age, sex, number of chronic medical conditions, education, and/or poverty status, each of major depression, panic disorder, posttraumatic stress disorder, and social phobia contributed independently and relatively equally to the prediction of disability and functional outcomes. Generalized anxiety disorder had relatively little impact on these indices when the effects of comorbid major depression were considered. Overall, anxiety disorders were associated with substantial decrements in preference-based health states.
CONCLUSIONS: These observations demonstrate that the presence of each of 3 common anxiety disorders (ie, panic disorder, posttraumatic stress disorder, and social phobia)-over and above the impact of chronic physical illness, major depression, and other socioeconomic factors-contributes in an approximately additive fashion to the prediction of poor functioning, reduced health-related quality of life, and more sick days from work. Greater awareness of the deleterious impact of anxiety disorders in primary care is warranted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16299426     DOI: 10.1097/01.mlr.0000185750.18119.fd

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  61 in total

1.  Impairment and functioning in a sample of primary care patients with generalized anxiety disorder: results from the primary care anxiety project.

Authors:  Risa B Weisberg; Courtney Beard; Maria E Pagano; Kristin M Maki; Larry Culpepper; Martin B Keller
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

Review 2.  Health-related quality of life in children and adolescents following traumatic injury: a review.

Authors:  Susanne P Martin-Herz; Douglas F Zatzick; Robert J McMahon
Journal:  Clin Child Fam Psychol Rev       Date:  2012-09

3.  Responsiveness of the anxiety/depression dimension of the 3- and 5-level versions of the EQ-5D in assessing mental health.

Authors:  Katelynn Crick; Fatima Al Sayah; Arto Ohinmaa; Jeffrey A Johnson
Journal:  Qual Life Res       Date:  2018-03-07       Impact factor: 4.147

Review 4.  Treatment for anxiety disorders: Efficacy to effectiveness to implementation.

Authors:  Michelle G Craske; Peter P Roy-Byrne; Murray B Stein; Greer Sullivan; Cathy Sherbourne; Alexander Bystritsky
Journal:  Behav Res Ther       Date:  2009-07-14

5.  Measuring Population Health in a Large Integrated Health System to Guide Goal Setting and Resource Allocation: A Proof of Concept.

Authors:  Elizabeth R Stevens; Qinlian Zhou; Kimberly A Nucifora; Glen B Taksler; Marc N Gourevitch; Matthew C Stiefel; Patricia Kipnis; R Scott Braithwaite
Journal:  Popul Health Manag       Date:  2018-12-04       Impact factor: 2.459

6.  Effects of syndemic psychiatric diagnoses on health indicators in men who have sex with men.

Authors:  Abigail W Batchelder; Karmel Choi; Sannisha K Dale; Catherine Pierre-Louis; Elsa W Sweek; Gail Ironson; Steven A Safren; Conall O'Cleirigh
Journal:  Health Psychol       Date:  2019-04-11       Impact factor: 4.267

7.  Eszopiclone treatment for insomnia: effect size comparisons in patients with primary insomnia and insomnia with medical and psychiatric comorbidity.

Authors:  Andrew D Krystal; W Vaughn McCall; Maurizio Fava; Hadine Joffe; Claudio N Soares; Holly Huang; Todd Grinell; Jacqueline Zummo; William Spalding; Randall Marshall
Journal:  Prim Care Companion CNS Disord       Date:  2012-07-05

8.  Likelihood of Attending Treatment for Anxiety Among Veteran Primary Care Patients: Patient Preferences for Treatment Attributes.

Authors:  Robyn L Shepardson; Jennifer S Funderburk
Journal:  J Clin Psychol Med Settings       Date:  2016-09

9.  The relationships between posttraumatic stress disorder severity, depression severity and physical health.

Authors:  Nina K Rytwinski; Jennifer S Avena; Aileen M Echiverri-Cohen; Lori A Zoellner; Norah C Feeny
Journal:  J Health Psychol       Date:  2013-02-28

10.  Analysis of health-related quality of life and costs based on a randomised clinical trial of escitalopram for relapse prevention in patients with generalised social anxiety disorder.

Authors:  C François; S A Montgomery; N Despiegel; S Aballéa; J Roïz; P Auquier
Journal:  Int J Clin Pract       Date:  2008-08-28       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.